ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NAVB Navidea Biopharmaceuticals Inc

0.0779
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High

Low
0.0626

52 Week Range

High
0.272

Day Low
Share Name Share Symbol Market Stock Type
Navidea Biopharmaceuticals Inc NAVB AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0779 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.0779 0.0779
Trades Shares Traded Average Volume 52 Week Range
0 0 - 0.0626 - 0.272
Last Trade Type Quantity Price Currency
- 0 US$ 0.0779 USD

Navidea Biopharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.99M 99.83M - 66k -17.22M -0.17 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Navidea Biopharmaceuticals News

Date Time Source News Article
22/12/202307:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
06/12/202310:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
02/12/202303:49Edgar (US Regulatory)Form 8-K - Current report
17/11/202308:55Edgar (US Regulatory)Form 8-K - Current report
24/10/202304:56Edgar (US Regulatory)Form 25-NSE - Notification filed by national security..
06/10/202312:01Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American’s..
06/10/202307:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
16/9/202305:42Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
11/9/202314:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
16/8/202307:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
12/8/202306:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202323:29Business WireNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing..

Historical NAVB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.270.2720.06260.10012486,132,248-0.1921-71.15%
3 Years1.662.190.06260.17093611,210,039-1.58-95.31%
5 Years2.235.35690.06260.6596015885,518-2.15-96.51%

Your Recent History

Delayed Upgrade Clock